Five Prime Therapeutics, Inc. FPRX

Five Prime Therapeutics, Inc. 951 Gateway Boulevard South San Francisco, CA 94080
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1175505

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Five Prime Therapeutics, Inc. has not been involved in any litigation in the PlainSite database.

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (17)

	Last Name	First Name	Middle Name	Firm	Location
	Fordis	Jean	Burke		WASHINGTON, DC
	Arrigo	Salvatore	J.		Washington, DC
	GUZMAN	MELISSA			MILWAUKEE, WI
	Scarr	Rebecca	B.		Glendale, WI
		Finnegan			Washington, DC
	Sc	Casimir	Jones		MIDDLETON, WI
	Dunn	Charity	K.		DUBLIN, CA
	SALGADO	WALESKA			Chicago, IL
	Recipon	Shirley			SOUTH SAN FRANCISCO, CA
	LOSSING	BRIGID			ANN ARBOR, MI
	Lossing	Brigid	A.		Thousand Oaks, CA
	Jacobson	Robert			St. Paul, MN
	Nudelman	Aaron	S.	Cooley LLP	Washington, DC
	Matovcik	Lisa	M.	Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	S.	Garrett	Arthur	Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Matovcik	Lisa	M.	Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Scarr	Rebecca	B.	Finnegan, Henderson, Farabow, Garrett & Dunn...	Palo Alto, CA

17 Rows Total

Filter By Form All Records 10-K 10-K/A 10-Q 10-Q/A 3 3/A 4 4/A 424B4 424B5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DRS DRS/A EFFECT PRE 14A REGDEX REGDEX/A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13G SC 13G/A SC TO-I SC TO-I/A UPLOAD From To

	Date	Entity	Form Number	Description
	2/15/2022		SC 13G/A
	5/17/2021		SC 13G/A
	4/26/2021		15-12B
	4/21/2021		EFFECT
	4/19/2021	Sarena Francis Willard	4	Statement of changes in beneficial ownership of securities
	4/19/2021		4	Statement of changes in beneficial ownership of securities
	4/19/2021	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	4/19/2021	White, David	4	Statement of changes in beneficial ownership of securities
	4/19/2021	Ringo William R	4	Statement of changes in beneficial ownership of securities
	4/19/2021		4	Statement of changes in beneficial ownership of securities
	4/19/2021	Dhingra, Kapil	4	Statement of changes in beneficial ownership of securities
	4/19/2021	Jensen, Peder	4	Statement of changes in beneficial ownership of securities
	4/19/2021		4	Statement of changes in beneficial ownership of securities
	4/19/2021	Schafer Carol	4	Statement of changes in beneficial ownership of securities
	4/19/2021	Lyons-Williams Lori	4	Statement of changes in beneficial ownership of securities
	4/19/2021	Civik Thomas	4	Statement of changes in beneficial ownership of securities
	4/16/2021		SC TO-T/A
	4/16/2021		SC 14D9/A
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		S-8 POS
	4/16/2021		POS AM
	4/16/2021		8-K	Current report pursuant to Section 13 or 15(d)
	4/16/2021		25-NSE
	4/15/2021		8-K	Current report pursuant to Section 13 or 15(d)
	4/13/2021		4	Statement of changes in beneficial ownership of securities
	4/8/2021		SC TO-T/A
	4/8/2021		SC 14D9/A
	4/6/2021		SC TO-T/A
	4/6/2021		SC 14D9/A
	3/22/2021		SC TO-T/A
	3/22/2021		SC 14D9/A
	3/22/2021		10-K	Annual report pursuant to Section 13 or 15(d)
	3/18/2021		SC TO-T
	3/18/2021		SC 14D9
	3/15/2021		SC 13D
	3/8/2021		SC14D9C
	3/8/2021		SC 13G/A
	3/8/2021	Biotechnology Value Fund L P Et Al	3	Initial statement of beneficial ownership of securities
	3/5/2021		SC14D9C
	3/5/2021		SC TO-C
	3/4/2021		SC14D9C
	3/4/2021		SC14D9C
	3/4/2021		SC TO-C
	3/4/2021		SC TO-C

730 Rows Total	Page 1 of 15 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	3/13/2025	Borges, Luis	Assignor	Application Publication	18939765 20250129166
	3/13/2025	Rankin, Andrew	Assignor	Application Publication	18939765 20250129166
	1/17/2025	Arvindan, Nallakkan	Assignor	Application Publication	17058108 20210215687	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	1/17/2025	Mehi, Stephen	Assignor	Application Publication	17058108 20210215687	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	1/17/2025	Ou, Guanqing	Assignor	Application Publication	17058108 20210215687	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	1/17/2025	Arvindan, Nallakkan	Assignor	Application Publication Patent	17058108 20210215687 12235264	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	1/17/2025	Mehi, Stephen	Assignor	Application Publication Patent	17058108 20210215687 12235264	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	1/17/2025	Ou, Guanqing	Assignor	Application Publication Patent	17058108 20210215687 12235264	Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening Enhanced Cytometry For Tissue Characterization And Screening
	6/14/2024	Zhang, Xiang	Assignor	Application Publication	18741328 20240317864	B7-h4 Antibody Dosing Regimens B7-h4 Antibody Dosing Regimens
	6/14/2024	Xiang, Hong	Assignor	Application Publication	18741328 20240317864	B7-h4 Antibody Dosing Regimens B7-h4 Antibody Dosing Regimens
	6/14/2024	Collins, Helen L.	Assignor	Application Publication	18741328 20240317864	B7-h4 Antibody Dosing Regimens B7-h4 Antibody Dosing Regimens
	6/14/2024	Inamdar, Sandeep P.	Assignor	Application Publication	18741328 20240317864	B7-h4 Antibody Dosing Regimens B7-h4 Antibody Dosing Regimens
	5/3/2024	Rankin, Andrew	Assignor	Application Publication	18543912 20240228653
	10/3/2023	Borges, Luis	Assignor	Application Publication Patent	18162991 20240092907 12195535	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	10/3/2023	Rankin, Andrew	Assignor	Application Publication Patent	18162991 20240092907 12195535	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	7/25/2023	Wong, Brian	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/25/2023	Masteller, Emma	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/25/2023	Hestir, Kevin	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/25/2023	Sikorski, Robert	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/25/2023	Hambleton, Julie	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/25/2023	Bellovin, David	Assignor	Application Publication	18069511 20230212299	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/24/2023	Meury, Marcel	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Wong, Terence	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Yuan, Shujun	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Barbee, Susannah D.	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Palumbo, Alessandro	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Zuberbuhler, Kathrin	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/24/2023	Falkowska, Emilia	Assignor	Application Publication	18248979 20230416382	Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There... Anti-c-c Chemokine Receptor 8 (ccr8) Antibodies And Methods Of Use There...
	7/10/2023	Powers, Janine	Assignor	Application Publication	18343944 20240000893	Medical Use Of Interferon-lambda For The Treatment Of Fibrosis Medical Use Of Interferon-lambda For The Treatment Of Fibrosis
	7/10/2023	Kellar, Danielle E.	Assignor	Application Publication	18343944 20240000893	Medical Use Of Interferon-lambda For The Treatment Of Fibrosis Medical Use Of Interferon-lambda For The Treatment Of Fibrosis
	3/28/2023	Borges, Luis	Assignor	Application Publication Patent	18162991 20240092907 12195535	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	3/28/2023	Rankin, Andrew	Assignor	Application Publication Patent	18162991 20240092907 12195535	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	10/10/2022	Palencia, Servando	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	10/10/2022	Pierce, Kristen	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	10/10/2022	Sikorski, Robert	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	10/10/2022	Powers, Janine	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	10/10/2022	Ghoddusi, Majid	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	10/10/2022	Krishnan, Kartik	Assignor	Application Publication	17818256 20230052212	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	8/29/2022	Wong, Brian	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Lee, Ernestine	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Masteller, Emma	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Hestir, Kevin	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Hambleton, Julie	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Powers, Janine	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Bellovin, David	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	8/29/2022	Sikorski, Robert, Dr.	Assignor	Application Publication	17812529 20240020210	Collector Conflict Resolution Collector Conflict Resolution
	7/20/2022	Palencia, Servando	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	7/20/2022	Pierce, Kristen	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	7/20/2022	Sikorski, Robert	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	7/20/2022	Powers, Janine	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	7/20/2022	Ghoddusi, Majid	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	7/20/2022	Krishnan, Kartik	Assignor	Application Publication	15358756 20170145102	Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ... Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents ...
	6/23/2022	Brennan, Thomas	Assignor	Application Publication	17742189 20240041979	Process For Producing Isocyanates Process For Producing Isocyanates
	6/23/2022	Busha, David	Assignor	Application Publication	17742189 20240041979	Process For Producing Isocyanates Process For Producing Isocyanates
	6/23/2022	Bellovin, David	Assignor	Application Publication	17742189 20240041979	Process For Producing Isocyanates Process For Producing Isocyanates
	6/23/2022	Sennino, Barbara	Assignor	Application Publication	17742189 20240041979	Process For Producing Isocyanates Process For Producing Isocyanates
	12/13/2021	Borges, Luis	Assignor	Application Publication	17258866 20220073617	Antibodies Binding to Vista at Acidic pH Antibodies Binding to Vista at Acidic pH
	12/13/2021	Rankin, Andrew	Assignor	Application Publication	17258866 20220073617	Antibodies Binding to Vista at Acidic pH Antibodies Binding to Vista at Acidic pH
	10/27/2021	Zhang, Xiang	Assignor	Application Publication	17366580 20220041737	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	10/27/2021	Xiang, Hong	Assignor	Application Publication	17366580 20220041737	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	10/27/2021	Hnatyszyn, James	Assignor	Application Publication	17366580 20220041737	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	10/27/2021	Collins, Helen L.	Assignor	Application Publication	17366580 20220041737	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	10/19/2021	Wong, Justin	Assignor	Application Publication	17173886 20210277130	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	10/19/2021	Wong, Brian	Assignor	Application Publication	17173886 20210277130	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	10/19/2021	Lin, Haishan	Assignor	Application Publication	17173886 20210277130	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	10/19/2021	Masteller, Emma	Assignor	Application Publication	17173886 20210277130	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	9/15/2021	Eureka Therapeutics, Inc.	Assignee	Application Publication	15574810 20180142016	Anti-ror1 Antibodies Anti-ror1 Antibodies
	9/15/2021	Eureka Therapeutics, Inc.	Assignee	Application Publication Patent	15574810 20180142016 11155615	Anti-ror1 Antibodies Anti-ror1 Antibodies Anti-ror1 Antibodies
	8/20/2021	Brennan, Thomas	Assignor	Application Publication	17432640 20220031806	Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative... Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative...
	8/20/2021	Sennino, Barbara	Assignor	Application Publication	17432640 20220031806	Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative... Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative...
	8/20/2021	Barbee, Susannah D.	Assignor	Application Publication	17432640 20220031806	Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative... Cd80 Extracellular Domain Fc Fusion Proteins For Treating Pd-l1 Negative...
	5/12/2021	Borges, Luis	Assignor	Application Publication	16982277 20210017283
	5/12/2021	Rankin, Andrew	Assignor	Application Publication	16982277 20210017283
	5/12/2021	Borges, Luis	Assignor	Application Publication Application	16982277 20210017283 12173069	Antibodies Binding to Vista at Acidic pH Antibodies Binding to Vista at Acidic pH
	5/12/2021	Rankin, Andrew	Assignor	Application Publication Application	16982277 20210017283 12173069	Antibodies Binding to Vista at Acidic pH Antibodies Binding to Vista at Acidic pH
	2/26/2021	Wong, Brian	Assignor	Application Publication	17026853 20210107986	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	2/26/2021	Masteller, Emma	Assignor	Application Publication	17026853 20210107986	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	2/26/2021	Reedquist, Kris	Assignor	Application Publication	17026853 20210107986	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	10/26/2020	Sikorski, Robert	Assignor	Application Publication	16911806 20210009700	Anti-CSF1R Antibodies for Treating PVNS Anti-CSF1R Antibodies for Treating PVNS
	10/26/2020	Hambleton, Julie	Assignor	Application Publication	16911806 20210009700	Anti-CSF1R Antibodies for Treating PVNS Anti-CSF1R Antibodies for Treating PVNS
	10/26/2020	Sankar, Nilacantan	Assignor	Application Publication	16911806 20210009700	Anti-CSF1R Antibodies for Treating PVNS Anti-CSF1R Antibodies for Treating PVNS
	10/2/2020	Glaxosmithkline Intellectual Property De...	Assignor	Application Publication Patent	16095974 20190125833 10799559	Nope For Treatment Of Pathological Muscle Loss And Weakness Nope For Treatment Of Pathological Muscle Loss And Weakness Nope For Treatment Of Pathological Muscle Loss And Weakness
	9/28/2020	Wong, Brian	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Lee, Ernestine	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Masteller, Emma	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Hestir, Kevin	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Sikorski, Robert	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Hambleton, Julie	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Powers, Janine	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/28/2020	Bellovin, David	Assignor	Application Publication	16646690 20210009697	Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa... Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pa...
	9/24/2020	Wong, Brian	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	9/24/2020	Masteller, Emma	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	9/24/2020	Hestir, Kevin	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	9/24/2020	Sikorski, Robert	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	9/24/2020	Hambleton, Julie	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	9/24/2020	Bellovin, David	Assignor	Application Publication	16808910 20200299392	Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance... Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cance...
	7/16/2020	Zhang, Xiang	Assignor	Application Publication	16613579 20200079856	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	7/16/2020	Xiang, Hong	Assignor	Application Publication	16613579 20200079856	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	7/16/2020	Hnatyszyn, James	Assignor	Application Publication	16613579 20200079856	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	7/16/2020	Collins, Helen L.	Assignor	Application Publication	16613579 20200079856	Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ... Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer ...
	7/14/2020	Rankin, Andrew	Assignor	Application Publication	16476814 20190330364	PSGL-1 Antagonists and Uses Thereof PSGL-1 Antagonists and Uses Thereof
	6/5/2020	Brennan, Thomas	Assignor	Application Publication	16608911 20200182858	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Jeffry, Ursula	Assignor	Application Publication	16608911 20200182858	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Sennino, Barbara	Assignor	Application Publication	16608911 20200182858	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Barbee, Susannah D.	Assignor	Application Publication	16608911 20200182858	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Brennan, Thomas	Assignor	Application Publication Patent	16608911 20200182858 11789010	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Jeffry, Ursula	Assignor	Application Publication Patent	16608911 20200182858 11789010	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Sennino, Barbara	Assignor	Application Publication Patent	16608911 20200182858 11789010	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	6/5/2020	Barbee, Susannah D.	Assignor	Application Publication Patent	16608911 20200182858 11789010	Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides Methods Of Treatment With Cd80 Extracellular Domain Polypeptides
	5/14/2020	Borges, Luis	Assignor	Application Publication	16493712 20200055936	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	5/14/2020	Rankin, Andrew	Assignor	Application Publication	16493712 20200055936	Antibodies Binding to VISTA at Acidic pH Antibodies Binding to VISTA at Acidic pH
	4/30/2020	Wong, Justin	Assignor	Application Publication	16737217 20200223931	Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
	4/30/2020	Vasquez, Maximiliano	Assignor	Application Publication	16737217 20200223931	Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
	4/30/2020	Wong, Justin	Assignor	Application Publication Patent	16737217 20200223931 11186646	Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
	4/30/2020	Vasquez, Maximiliano	Assignor	Application Publication Patent	16737217 20200223931 11186646	Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R) Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
	4/28/2020	Baker, Kevin	Assignor	Application Publication	16786158 20200237927	Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Wong, Brian	Assignor	Application Publication	16786158 20200237927	Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Brennan, Thomas	Assignor	Application Publication	16786158 20200237927	Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Masteller, Emma	Assignor	Application Publication	16786158 20200237927	Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Bellovin, David	Assignor	Application Publication	16786158 20200237927	Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Baker, Kevin	Assignor	Application Publication Patent	16786158 20200237927 11559583	Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy... Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Wong, Brian	Assignor	Application Publication Patent	16786158 20200237927 11559583	Combination Therapy for Cancer Combination Therapy for Cancer Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy...
	4/28/2020	Brennan, Thomas	Assignor	Application Publication Patent	16786158 20200237927 11559583	Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy... Combination Therapy for Cancer Combination Therapy for Cancer
	4/28/2020	Masteller, Emma	Assignor	Application Publication Patent	16786158 20200237927 11559583	Combination Therapy for Cancer Combination Therapy for Cancer Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy...
	4/28/2020	Bellovin, David	Assignor	Application Publication Patent	16786158 20200237927 11559583	Combination Therapy for Cancer Combination Therapy for Cancer Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy...
	3/24/2020	Wong, Brian	Assignor	Application Publication	15574810 20180142016	Anti-ror1 Antibodies Anti-ror1 Antibodies
	3/24/2020	Masteller, Emma	Assignor	Application Publication	15574810 20180142016	Anti-ror1 Antibodies Anti-ror1 Antibodies
	3/24/2020	Wong, Brian	Assignor	Application Publication Application	15574810 20180142016 11155615	Anti-ror1 Antibodies Anti-ror1 Antibodies
	3/24/2020	Masteller, Emma	Assignor	Application Publication Application	15574810 20180142016 11155615	Anti-ror1 Antibodies Anti-ror1 Antibodies
	3/3/2020	Rankin, Andrew	Assignor	Application Publication	16506754 20200079848	Antibodies Binding to ILT4 Antibodies Binding to ILT4
	3/3/2020	Chen, Diana Yuhui	Assignor	Application Publication	16506754 20200079848	Antibodies Binding to ILT4 Antibodies Binding to ILT4
	3/3/2020	Rankin, Andrew	Assignor	Application Publication Patent	16506754 20200079848 11401328	Antibodies Binding to ILT4 Antibodies Binding to ILT4 Antibodies Binding to ILT4
	3/3/2020	Chen, Diana Yuhui	Assignor	Application Publication Patent	16506754 20200079848 11401328	Antibodies Binding to ILT4 Antibodies Binding to ILT4 Antibodies Binding to ILT4
	11/27/2019	Palencia, Servando	Assignor	Application Publication	16003590 20190000920	Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Harding, Thomas	Assignor	Application Publication	16003590 20190000920	Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Hestir, Kevin	Assignor	Application Publication	16003590 20190000920	Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Long, Li	Assignor	Application Publication	16003590 20190000920	Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Palencia, Servando	Assignor	Application Publication Patent	16003590 20190000920 10537611	Methods of Treating Lung Cancer Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Harding, Thomas	Assignor	Application Publication Patent	16003590 20190000920 10537611	Methods of Treating Lung Cancer Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Hestir, Kevin	Assignor	Application Publication Patent	16003590 20190000920 10537611	Methods of Treating Lung Cancer Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	11/27/2019	Long, Li	Assignor	Application Publication Patent	16003590 20190000920 10537611	Methods of Treating Lung Cancer Methods of Treating Lung Cancer Methods of Treating Lung Cancer
	7/17/2019	Powers, Janine	Assignor	Application Publication	16469236 20190374610	Medical Use Of Interferon-lambda For The Treatment Of Fibrosis Medical Use Of Interferon-lambda For The Treatment Of Fibrosis
	6/5/2019	Schmidt, Maike	Assignor	Application Publication	16111064 20190085080	B7-h4 Antibodies And Methods Of Use Thereof B7-h4 Antibodies And Methods Of Use Thereof
	6/5/2019	Adimab, LLC	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Kaplan, Charles	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Borges, Luis	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Miller, Kathy	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Bellovin, David	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Houser, Derrick	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Brattich, Gloria	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Kemp, Felicia	Assignor	Application Publication	16111064 20190085080
	6/5/2019	Ghoddusi, Majid	Assignor	Application Publication	16111064 20190085080
	5/14/2019	Wong, Brian	Assignor	Application Publication	16256311 20190248908	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	5/14/2019	Masteller, Emma	Assignor	Application Publication	16256311 20190248908	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	5/14/2019	Reedquist, Kris	Assignor	Application Publication	16256311 20190248908	Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	5/14/2019	Wong, Brian	Assignor	Application Publication Patent	16256311 20190248908 10822421	Methods Of Treating Conditions With Antibodies That Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	5/14/2019	Masteller, Emma	Assignor	Application Publication Patent	16256311 20190248908 10822421	Methods Of Treating Conditions With Antibodies That Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	5/14/2019	Reedquist, Kris	Assignor	Application Publication Patent	16256311 20190248908 10822421	Methods Of Treating Conditions With Antibodies That Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat... Methods of Treating Conditions with Antibodies that Bind Colony Stimulat...
	4/19/2019	Sikorski, Robert	Assignor	Application Publication Patent	16015371 20190119390 10730949	Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies
	4/19/2019	Hambleton, Julie	Assignor	Application Publication Patent	16015371 20190119390 10730949	Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies
	4/19/2019	Sankar, Nilacantan	Assignor	Application Publication Patent	16015371 20190119390 10730949	Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies Method Of Treating Pvns With Anti-csf1r Antibodies
	4/12/2019	Wong, Brian	Assignor	Application Publication	16243510 20190202921
	4/12/2019	Masteller, Emma	Assignor	Application Publication	16243510 20190202921
	4/12/2019	Hestir, Kevin	Assignor	Application Publication	16243510 20190202921
	4/12/2019	Sikorski, Robert	Assignor	Application Publication	16243510 20190202921
	4/12/2019	Hambleton, Julie	Assignor	Application Publication	16243510 20190202921
	4/12/2019	Bellovin, David	Assignor	Application Publication	16243510 20190202921

167 Rows Total

Five Prime Therapeutics, Inc. has not been involved in any trademark assignment transactions in the PlainSite database.

Corporate Family (34)

Track Corporate Family

• Atwood, Brian G., None
• Baker Kevin Paul, None
• Belsky, Marc, None
• Berger Franklin M, None
• Biotechnology Value Fund L P Et Al, None
• Borges, Luis, None
• Bvf Gp Holdings LLC, None
• Bvf Partners L P/il, None
• Civik Thomas, None
• Cohen, Fred E., None
• Collins Helen Louise, None
• Dhingra, Kapil, None
• Douglas R Lee, None
• Gross, Phillip, None
• Gujrathi, Sheila, None
• Hambleton, Julie, None
• Irving, Bryan, None
• Jensen, Peder, None
• Kavanaugh, William Michael, None
• Knickerbocker Aron Marc, None
• Lampert Mark N, None
• Lyons-Williams Lori, None
• Mcdade Mark, None
• Nicholson Garry A, None
• Pfizer, Inc., None
• Ringo William R, None
• Rubinstein Linda M, None
• Sarena Francis Willard, None
• Schafer Carol, None
• Sikorski Robert Steven, None
• Smith, David V., None
• White, David, None
• Williams, Lewis T., None
• Wong Brian Russell, None

Subsidiaries

• Atwood, Brian G.
• Douglas R Lee
• Sarena Francis Willard
• Berger Franklin M
• Cohen, Fred E.
• Jensen, Peder
• Mcdade Mark
• Belsky, Marc
• Hambleton, Julie
• Kavanaugh, William Michael
• Knickerbocker Aron Marc
• Williams, Lewis T.
• Ringo William R
• Gross, Phillip
• Dhingra, Kapil
• Gujrathi, Sheila
• Baker Kevin Paul
• Sikorski Robert Steven
• Borges, Luis
• Collins Helen Louise
• Nicholson Garry A
• Irving, Bryan
• Smith, David V.
• White, David
• Schafer Carol
• Lyons-Williams Lori
• Bvf Partners L P/il
• Lampert Mark N
• Civik Thomas
• Pfizer, Inc.
• Wong Brian Russell
• Rubinstein Linda M
• Bvf Gp Holdings LLC
• Biotechnology Value Fund L P Et Al

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.